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INTRODUCTION 
 
The acquired Immuno Deficiency Syndrome (AIDS) caused by 
a retrovirus variously termed Human Immuno Deficiency Virus – 1 
(HIV-1) Human T-Lymphocytic Virus III or Lymphadenopathy 
associated virus is no longer a rare or exotic disease. 
 
Since its first description in June 1981 it is now a Worldwide 
Pandemic.  In the early years of epidemic, nervous system 
involvement was not widely recognized.  It is now recognized that 
were level of neuraxis can be involved and at least one third of 
patients with advanced HIV infection will develop neurological 
complications during the course of their illness and 10% of cases 
neurological problems may be first sign of development of AIDS.  But 
at autopsy, more than 80% of patients show evidence of cerebral 
pathology ranging from HIV encephalitis, opportunistic infections or 
lymphomas and some evidence of peripheral neuropathy. 
 
 Neurological manifestations of HIV consists of CNS 
complications caused directly by HIV, and include cognitive disorders 
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and other CNS disease such as myelopathy and the demyelinating 
neuropathies, and the secondary disorders caused by opportunistic 
infections, neoplasm, cerebrovascular events, as also the effects of 
metabolic derangements and medications. 
 
Considering the protean manifestations of neurological illness 
in HIV infected, an analysis of neurological manifestations in this 
subset of Patients was made. 
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AIM OF THE STUDY 
 
To study the spectrum of neurological manifestations in HIV 
infected subjects at various level. 
 
To study the correlation of neurological manifestations with 
CD4 count in these subjects. 
 
 4
REVIEW OF LITERATURE 
 
 Clinical Disease of Nervous System Accounts for a Significant 
Degree of Morbidity in High Percentage of Patients with HIV 
Infection Pucconi (15%), 1989; Wadia (20%), 2001; Vijay Teja 
(36%), 2005. It is both debilitating and life threatening Neurological 
complications typically occur with advanced disease and profound 
Immunosuppression. Autopsy Studies of HIV Disease clearly shows 
pathological abnormalities of Central Nervous System is around 60-
75% (K.S. Shankar, Anita et al., 2002). 
 
Neuropathogenesis: 
 HIV- Infected individuals can experience a variety of 
neurological abnormalities due either to opportunistic infections and 
neoplasm (or) to direct effects of HIV or its products. 
 
 Main cell types infected in brain are the perivascular 
macrophages and microglial cells. 
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 Precise mechanism of HIV enters the brain by induce adhesion 
molecules such as E-selectin and vascular cell adhesion molecule 
(VCAM-1) on brain endothelium. HIV gp 120 enhances expression of 
Inter Cellular adhesion molecule (ICAM – 1) in glial cells. They 
promote syncita formation. Virus isolation from brain is R5 strains. 
 
 HIV  infected individuals may manifest white matter lesions as 
well as neuronal loss. Viral proteins gp 120 and tat trigger release of 
endogenous neurotoxins from macrophages and astrocytes. 
 
 HIV – 1 nef and tat induce chemotaxis of leucocytes and release 
of neurotoxins from monocytes. Macrophage Derived Neurotropic 
Factor (MDNF-1) to kill neurons via N-Methyl D-Aspartate receptor.  
gp 120 infected monocytes cause neurotoxicity by Antagonise 
vascular peptides. 
 
 Monocyte derived cytokines TNF-α, IL-1, IL-6, TGF-β, IFN-γ, 
Platlet Activating Factorand Endothelin contribute neurotoxic effects. 
Increased production of Eicosanoids, Nitric Oxide and Quinolinic 
Acid contribute to Neurotoxicity. 
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 Astrocyte derived IL-6 induce HIV expression in infected cells 
and down regulate macrophage produced neurotoxins. HIV infected 
individuals with E4 allele for apoE increased risk for AIDS 
encephalopathy and peripheral neuropathy. 
 
Primary HIV Infection of the Brain 
HIV-1 associated dementia complex 
 An AIDS-Defining illness, most HIV-infected patients have 
some neurologic problem during the course of their disease. Incidence 
of HIV Dementia Central of Disease Control (7%), 1996; 
Balakrishnan (10%), 1989; Baller et al (7-14%), 2001. 
 
 Brain Atrophy characterized by sulcal widening, ventricular 
dilatation and meningeal fibrosis observed at autopsy in patients with 
HIV dementia. With advanced immunosuppression, HIV Dementia 
present as sole manifestation. 
 
 Features include disturbed intellect, fatigue, malaise, Headache, 
loss of sexual drive. Increased forgetfulness, difficulty concentrating, 
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problems reading and slowness at wide variety of tasks (Navia et al. 
1986). 
 
 Physical examination reveals Hallmark of advanced AIDS, 
wasting, alopecia, sebborheic dermatitis and generalized 
lymphadenopathy. The patient exhibits slow mental processing (Brady 
Phrenia), abnormalities of saccadic and pursuit movements, 
diminished facial expression, hypophonia, impaired co-ordination, 
balance and tremor. 
 
 CSF shows mono nuclear pleocytosis in 1/5th of individuals, 
2/3rd have increased protein – 200 mg/µl; oligoclonal band frequently 
noted (KATZ et al, 2001). Recently HIV p24 Ag, β2-microglobulin, 
neoptrin and calprotectin (2%) (Dunlop et al., 1991) are demonstrated 
in CSF in patients with HIV dementia. 
 
 CT brain shows brain atrophy, (Central and Contical patterns); 
MRI shows “punctate” lesion. EEG and other Electrophysiological 
studies not helpful.  The recent studies shows (SCHMITT et al, 2000) 
HIV dementia improved with high doze of Zidouvidine. 
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 The diagnosis of dementia accomplished by Mini Mental Score 
Examination (MMSE). It is advisable for all patients with a diagnosis 
of HIV infection to have baseline MMSE. 
 
 JJ Siditis and Price, 1997 – staging system of HIV Dementia 
used in both clinical and research areas. 
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Severity Scales of Dementia 
Stage Dementia 
0 Normal mental and motor function.  Neurological signs are 
within the normal age - appropriate spectrum. 
0.5 Equivocal or subclinical: Absent, minimal, or equivocal 
symptoms without impairment of work or capacity to perform 
ADL.  Examination may be normal mildly abnormal; signs may 
include reflex changes (e.g. generalized increase in deep tendon 
reflexes with active jaw jerk, snout or glabellar sign) or midly 
slowed ocular movements, but without clear slowing of 
extremity movements or loss of their dexterity or strength. 
1 Mild: Able to perform all, but the more demanding aspects of 
work or ADL but with unequivocal evidence (symptoms or 
signs including performance on neuropsychologic testing) of 
intellectual or motor impairment.  The abnormal motor signs 
usually include slow or clumsy movements or extremities. 
2 Moderate: Able to perform basic activities of self care at home 
but cannot work or maintain more demanding aspects of daily 
life (e.g. maintain finances, read text more complex than a 
tabloid newspaper) 
3 Severe: Major intellectual incapacity (cannot follow news or 
personal events, cannot sustain complex conversation, 
considerable slowing of all output or motor liability. 
4 End Stage: Nearly vegetative.  Intellectual and social 
comprehension and output are at a rudimentary level.  Nearly or 
absolutely mute. 
 
 10
Aseptic Meningitis: 
 Pullioni et al, (1989) reported 2 cases of Aseptic meningitis in 
44 patients.  Rosenbaulm et al (1988) reported 21 cases with aseptic 
meningitis.  
 
Aseptic meningitis seen in any but very late stages of HIV 
infection. In acute primary infection – syndrome of Headache, 
photophobia and meningismus are present cranial nerve involvement, 
predominantly VII and occasionally V / VIII. 
 
CSF shows lympocytic pleocytosis, elevated protein level and 
normal glucose level. This spontaneously resolve with in 2 to 4 weeks; 
it is rare following the development of AIDS. 
 
Neuromuscular Disorders 
 Prospective neurological examination of patients with advanced 
AIDS will reveal evidence of peripheral neuropathies in as many as 
50% (Berger et al, 1994). Peripheral neuropathies occurring with HIV 
infection are diverse. HIV mediated, immune mediated, infections 
(CMV, HZV, Syphillitic, Mycobacterium avium complex); nutritional 
(Vit-B12; Folate deficiency); Toxicity of the therapeutic drugs, 
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notably dideoxyinosine (ddI), dideoxycytidine (ddC) and stavudine 
(d4T) are responsible for increasing number of cases of neuropathy. 
 
 Four types of neuropathy are important to recognize, either 
because of their high prevalence or their therapeutic implications, or 
both. They are 
 
1. Distal symmetric polyneuropathy (DSPN) 
2. Mononeuropathy multiplex 
3. Inflammatory demyelinating polyneuropathy 
4. Progressive polyradiculopathy. 
 
SN Pujari et al (2001) from India reported 17% cases in his 
series, depending on the study population and the method of case 
ascertainment, clinical, electrophysiologic or pathologic evidence of 
peripheral neuropathy is present in about one - third to nearly 100% of 
patients with advanced HIV disease.  The incidence of neuropathy 
increases with declining CD4 cell count and advancing systemic HIV 
disease.  
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Distal symmetrical Sensorimotor neuropathy 
 Develops generally in late stage of disease in about 30% of 
patients. Identical presentation of sensory neuropathy seen with 
dideoxyinosine (ddI), dideoxycytidine (ddC) and stavudine (d4T); 
patient had painful paraesthesias, dysesthesias and spontaneous pain in 
feet. 
 
 Distal weakness, imparted vibration sense and hyperalgesia 
frequently detected. The most common signs of DSP in AIDS are 
depressed or absent reflexes at ankles, relative to the knees.  The 
presence of hyperactive knee reflexes and depressed ankle reflexes 
may indicate concurrent myelopathy and neuropathy which is a 
common association in HIV infected individuals.  Vibratory 
thresholds are increased, and pinprick and temperature are reduced in 
a stocking and glove distribution, whereas joint position sensation is 
relatively normal.  Weakness is generally restricted to intrinsic foot 
muscles, unless DSP is very advanced, or other neurologic disorders 
are also present. 
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 Nerve conduction study shows decreased sensory potentials; 
neurophysiological studies suggest demyelination; nerve biopsy (Sural 
nerve) shows epineural and endoneural inflammation. 
 
 Symptomatic theraphy helpful including combination of 
Tricyclic and Carbamazepine, but non reverse primary disorders. 
 
Inflammatory demyelinating polyneuropathy 
 Both acute Gullian-Barre syndrome and Cronic inflammatory 
demyelinating polyradiculopathy occur with HIV infection. Both are 
rare and tend to occur in patients with early in stage of their HIV 
infection with immunological status is fairly well preserved (Simpson 
et al., 1992). 
 
Acute Inflammatory Demyelinating Polyneuropathy (AIDP) is 
characterized by rapidly progressive weakness in distal and proximal 
muscles of two or more limbs associated with generalized are flexia.  
Occasionally, bilateral facial weakness may be the presenting 
symptom.  The clinical progression of Acute Inflammatory 
Demyelinating Polyneuropathy (AIDP) is usually rapid and reaches its 
peak within the first 4 weeks of neurologic illness, with involvement 
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of respiratory muscles in the most severe cases.  Chronic 
Inflammatory Demyelinating Polyneuropathy (CIDP) is distinguished 
by a more slowly progressive clinical course that may be monophasic 
or relapsing over several months. 
 
 Nerve conduction study show features compatible with 
demyelinating neuropathy. CSF examination reveals normal to 
increased protein 200 mg/dl with mono nuclear pleocytosis (50 or 
more cells /µl), a differentiating feature from HIV seronegative 
Gullian-Barre Syndrome or Chronic Inflammatory Demyelinating 
Polyradiculopaty.   
 
In contradiction to typical Gullian-Barre syndrome a CSF 
cytoalbuminocytological dissociation occurs only in minority of 
affected AIDS patients (Behar R, 1987). 
 
Plasmapheresis and I.V. Immunoglobulin may be associated 
with striking improvement. 
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Mononeuritis Multiplex (MM) 
 Rarely observed with HIV infection, cranial, peripheral or 
spinal nerves many be affected (Simpson et al., 1992). This disorder is 
usually attributed to immune complex deposition resulting in a 
necrotising vasculitis. 
 
 Other casues of similar clinical picture, Herpeszoster, 
cytomegalovirus and lymphmatous nerve root infiltration must be 
considered in differential diagnosis. 
 
Patients with Mononeuritis Multiplex (MM) have asymmetric 
or proximal involvement of peripheral nerves and preservation of 
tendon reflexes in asymptomatic distributions.  The typical neurologic 
presentation includes multifocal sensory and motor abnormalities in 
the distribution of cutaneous nerves, mixed nerves and nerve roots.  
Cranial neuropathies are also a frequent feature of Mononeuritis 
Multiplex (MM). 
 
 Signs of focal or asymmetric multifocal axonal lesions and 
Electrodiagnositic abnormalities (Britton, Lange et al, 1987). 
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Progressive polyradiculopathy 
 This is due to cytomegalovirus. Which it recognized early may 
be treatable and reversible with Gancillovir or Foscarnet. 
 
The clinical presentation of in characterized by radiating pain 
and parasthesias in the caudaequina distribution, followed by rapidly 
progressive flaccid paraparesis, lower extremity areflexia and mild 
sensory loss and sphincter dysfunction.  The upper extremities may be 
involved late in the course of polyradiculopathy.  The CSF findings in 
most patients with progressive polyradiculopathy are characterized by 
marked polymorphonuclear pleocytosis, elevated protein and cultures 
are positive for CMV in about half of the patients.  The most 
prominent electrophysiologic abnormalities in Progressive Poly 
Radiculopathy (PP) are widespread denervation in lower extremity 
and lumbar paraspinal muslces, accompanied by abnormal late 
responses in affected distributions.  In most cases Progressive Poly 
Radiculopathy (PP) has a poor prognosis if untreated, with a mortality 
rate of nearly 100% and a mean duration of illness from onset of 
neurologic symptoms to death ranging from 2 to 30 days. 
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Myopathy 
 Numerous cases of HIV associated myopathy were reported by 
several groups (Bender, 1998; Carson, 1991). Polymyositis 
characterized by proximal muscle weakness, myalgias, excessive 
fatigability and increase in serum creatine kinase. Fibrous tissue 
proliferation, necrosis and phagovytosis of muscle fibres, 
accompanied by an intense inflammatory infiltrates are observed in 
Histopathalogical Examination of involved muscles (Foveretto et al., 
1991). 
 
Prolonged use of Zidouvidine therapy results in myopathy. The 
illness characterized by severe myalgias, proximal weakness and 
muscle wasting, often striking involvement of Gluteal muscles and 
following treatment with high doses of drug for 6-18 months. This due 
to interfere with function of mitochondrial polymerases. Red ragged 
fibres are histologic hall mark of Zidouvidine induced myopathy. This 
is reversible following discontinuation of drug. 
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Spinal cord disorders 
Vacuolar myelopathy (VM) 
The most common spinal cord disease complicating HIV 
infection is HIV associated vacuolar myelopathy.  The pathologic 
finding of noninflammatory vacuolation of myelin, particularly in the 
lateral and the posterior columns of the spinal cord, characterizes VM.  
Upper thoracic cord is affected most commonly, but cervical 
pathology is well described and occasionally diffuse cord changes are 
seen. 
 
The clinical features of HTV–1 related VM have been 
systematically studied.  In an autopsy based clinicopathological 
correlation, Dal Pan et al found that 15 of 56 patients with 
pathologically confirmed Vacuolar Myelopathy had clinical evidence 
of myelopathy.  Mild to moderate limb weakness were present in all 
cases, with severe weakness limited to the most advanced cases.  Knee 
hyperreflexia was common as were lower limb spasticity (eight of 15, 
53%) and gait spasticity (60%).  A sensory ataxia was seen in 20% of 
cases.  A coexistent distal sensory neuropathy with ankle areflexia or 
hyporeflexia was also common (eight of 15,53%).  A discrete thoracic 
sensory level was seen in two of 15 cases (13%).  Vibration and 
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position sense loss were common.  Bowel and bladder dysfunction 
were seen in only one case.  In all cases, the development was slowly 
progressive, with onset of symptoms ranging from 3 to 16 weeks 
before the diagnosis of myelopathy.  The development of symptomatic 
myelopathy is more frequent in patients with pathologically more 
severe VM. 
 
INTRACRANIAL OPPORTUNISTIC INFECTIONS 
Toxoplasma gondii 
Central Nervous System toxoplasmosis now represents the most 
common focal brain lesion in patients with AIDS and possibly the 
most common opportunistic infection (Synder H.S. et al, 1989). But its 
incidence is decreasing in era of HAART. 
 
 It is most common from France and Caribbean. In patients with 
AIDS, over 95% of toxoplasmic encephalitis is due to reactivation of a 
chronic (latent) infection.  For most HIV infected patients, 
toxoplasmic encephalitis (TE) develops when the CD4 + T 
lymphocyte count CD4T count) falls below 100/mm3. 
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 It is 10 times more common in patients with antirodies to 
organism than seronegative. Most Toxoplasmosis in the AIDS patient 
is most frequently manifested by toxoplasmic encephalitis, usually 
alone or less frequently as part of multiorgan infection.  Isolated organ 
involvement without CNS disease is uncommon, TE most frequently 
presents (50 to 89%) with a subacute onset of neurological deficits 
with or without evidence of generalized cerebral dysfunction.  Less 
often (15 to 25%), seizures may be the initial manifestation.  The 
clinical presentation varies from an insidious process evolving over 
several weeks to a more acute, at times fulminant course.  
Abnormalities associated with focal lesions include hemiplegia, 
hemisensory loss, hysphasia.  aphasia, movement disorders 
(hemichorea and hemiballismus), ataxia, diplopia cranial nerve 
palsies, cerebellar tremor, severe localized headache, Parkinsonian 
syndrome, and intractable hiccoughs.  Abnormalities attributable to 
generalized cerebral dysfunction include lethargy, confusion, coma 
and global cognitive impairment similar to AIDS related dementia. 
 
 MRI shows multiple lesion in multiple location (Balakrishnan et 
al, 1994). These lesion exhibit inflammation and central necrosis, as a 
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result demonstrate ring enhancement on contrast MRI (Becker P.S. et 
al., 1995). 
 
 In double contrast CT evidence of surrounding edema present 
(Kumar et al., 1995). 
 
 In addition to Toxoplasmosis, the differential diagnosis of 
single or multiple enhancing mass lesion in HIV infected patients 
includes primary CNS lymphoma, TB or Fungal or Bacterial Abscess 
(Calzada Lopaz et al., 1994).  
Definitive diagnosis is Biopsy. 
 
In CSF analysis, free extracellular tachyzoites, and CYST forms 
identified with wright straining of cytocentrifuge preparations 
(Dement S.H. et al., 2003). 
 
CSF shows low glucose (20 mg/dl) persisted for 10 days. (Cox 
et al., 2002). Cytocentrifuge, Wright stain superior to multipore filter 
papanicolaou stain preparation (Gupta et al., 2004). 
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Cryptococcus neoformans 
 This is extraordinarily common in AIDS patients, with reported 
incidence varying Wadia (2001), (34%), Levy (1989) (41%), Koppel 
(47%), Recart (2001) (39%). 
 
 Afro-Americans and I.V. Drug Abusers at increased risks. 
 
 Persistent head ache (universal complaint), Nausea, vomiting, 
mental status changes, photophobia, blurred vision, fever, 
meningismus also common. Less frequently observed are cranial 
nerve palsies, Hemiparesis, Language disturbances, seizure, cerebellar 
degenration and psychosis. 
 
 Typical locations are Brainstem and Basal ganglia.  Intracranial 
pressure elevation and sudden clinical deterioration from Herniation 
are common. Pathological examination reveals a basilar, chronic 
meningsis that is neither thick nor exudative. 
 
 Diffuse or focal opacifications of leptomeninges, small nodules 
and cystic lesion composed of clusters of budding yeast with reactive 
gilosis in basal Ganglia. 
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The CT of the head is normal or shows cerebral atrophy in 75 to 
90% of cases. Non-enhancing and contrast enhancing lesions 
presenting as either nodular or ring like patterns, particularly in the 
basal ganglia are seen.  CSF can be normal or show mononuclear 
pleocytosis, elevated protein, low glucose and high opening pressure.  
India ink preparations are positive in 72 to 88% of patients.  
Determination of CSF Cyptococcal Antigen (CRAG) titre is essential 
because this may be the only CSF abnorrmality; latex agglutination of 
CSF for Cryptococcal antigen has a sensitivity of 91% to 100%.  A 
positive CSF culture is the definitive diagnostic test for Cryptococcal 
meningitis and the main entry criteria in published series.  Being the 
gold standard, its sensitivity approaches by definition 100%. 
 
Mortality rate with cryptococcal meningitis high. This is due to 
elevated intracranial pressure. 
 
Other Fungal Infections 
In addition to cryptococcal meningiits, other CNS fungal 
infections such as Histoplamosis, Coccidioidomycosis, Blastomycosis 
and Aspergillosis have been reported. 
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Progressive multifocal leucoencephalopathy (PML) 
Progressive multifocal leucoencephalopathy (PML) is a 
demyelinating disease of the central nervous system that results from 
infection of oligodendrocytes with JC virus, a papovavirus.  It affects 
approximately 4 to 8% of patients with advanced HIV disease.  It is a 
subacute or chronic progressive illness most often characterised by 
focal neurologic findings such as hemiparesis, gait abnormalities and 
visual field cuts, and mental status and personality changes.  
Dementia, encephalopathy and coma can occur with fulminant 
disease, Seizures are uncommon, but not rare. 
 
Radiographic imaging provides the strongest support in 
diagnosing Progressive multifocal leucoencephalopathy (PML) but 
presently confirmation requires brain biopsy.  Affecting the white 
matter, generally not enhancing with contrast and exhibiting no mass 
effect, the hypodense lesions of PML on CT of the brain reveal areas 
that may have a “scalloped” appearance as a result of the subcortical 
fibers lying beneath the cortex.  The lesions have a predilection for the 
frontal and parieto-occipital lobes, may occur virtually anywhere.  The 
brainstem or cerebellum may be solely involved in upto 15% of cases. 
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Demyelination observed with HIV associated dementia may be 
radiographically indistinguishable from that of Progressive multifocal 
leucoencephalopathy (PML).  Clinically however PML is associated 
with focal neurological disease and is much more rapidly progressive.  
Radiographic distinctions include a greater propensity of lesions to 
involve the subcortical white matter, its hypointensity on T1 weighted 
images and its rare enhancement. 
 
Routine CSF evaluation is nondiagnostic and is usually normal 
or reveals only nonspecific changes such as mild pleocytosis or 
protein elevation.  CSF PCR detection of JC virus DNA has become 
the successful tool in the diagnosis of PML. 
 
Viral encephalitis 
Herpes simplex virus typically cause acute hemorrhagic 
necrotizing encephalitis with predilection for subfrontal and medial 
temporal lobes.  In AIDS patients HSV encephalitis presents with 
typical clinical features which include headache, fever and variable 
combinations of seizures, behavioral and cognitive changes, focal 
signs and ultimately obtundation.  Definitive diagnosis often requires 
 26
brain biopsy, but CSF PCR would reduce the need for tissue 
diagnosis. 
 
Herpes Zoster virus 
Herpes zoster virus infection of the nervous system may result 
in radiculitis.  characterized by painful vesicular cutaneous eruptions 
involving one or several dermatomes.  It also causes subacute 
encephalitis in a number of AIDS patients with clinical features which 
include lethargy, confusion and variable focal findings including 
cranial neuropathies.  Myelitis due to herpes zoster had been described 
in imunocompromised patients including AIDS patients with clinical 
features such as subacute progression of motor weakness, sensory 
deficits and sphincter disturbances in varying combinations that 
evolve over weeks. 
 
Cytomegalovirus 
Of the human herpes viruses, CMV is the major cause of 
morbidity in AIDS patients and is frequently the cause of death. 
 
CMV encephalitis presents as a subacutely progressive diffuse 
encephalitis evolving over several weeks and characterized by 
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confusion and imparied sensorium, with variably associated cranial 
neuropathies, ataxia and motor weakness.  Alternatively the 
presentation may result in focal neurological symptoms corresponding 
to the location of discrete parenchymal lesions, which may progress to 
a more diffuse encephalitis.  Signs of meningitis may be present.  
Median survivals following neurological presentation in small series 
are about a month. 
 
Several recent retrospective studies suggest that polymerase 
chain reaction amplification technique to detect CMV specific DNA in 
CSF samples may be a highly sensitive and specific diagnostic test for 
CMV infection of the CNS. 
 
Necrotizing myelitis attributable to CMV in AIDS presents has 
been reported by number of authors.  Clinical features include 
paraplegia, urinary retention and hypoesthesia, typical of myelopathy. 
 
CMV polyradiculomyelitis in patients with AIDS presents 
subacutely with paraesthesias or pain, progressive hypotonic 
weakness, areflexia and variable sensory deficits ascending from the 
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lower extremities to involve spinal cord, upper extremities and cranial 
nerves in some patients. 
 
Neurotuberculosis 
Tuberculosis has become an increasingly common problem in 
HIV – infected persons and extrapulmonary involvement is seen in 
60% of cases.  In patients with HIV - related tuberculosis positive CSF 
cultures are obtained in 3% to 10% of the time.  Given the difficulty of 
culturing this organism from CSF, this implies an even higher rate of 
CNS complication and typically presents as a subacute meningitis. 
Headache and fever are noted in the majority of cases with 
encephalopathy, particularly if there is elevated intracranial pressure.  
Cranial nerve abnormalities and frank meningeal signs are less 
common.  The CSF analysis usually demonstrates a Iymphocytic 
pleocytosis with a total cell count in the range of 200 to 500/mm3, 
hypoglycorrhachia is also commonly observed.  Two large series 
suggest that the clinical presentation, overall CSF profile and 
prognosis are identical in patients with and without HIV infection.  
The only difference between seropostive and seronegative patients is 
an increased incidence of intracerebral mass lesions in the HIV 
infected group (60% versus 14%). 
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Isolated CNS tuberculomas may present without concomitant 
tuberculous meningitis.  Their characteristics on cerebral imaging 
studies have varied; some appears as ring enhancing lesions while 
others are hypodense and non-enhancing lesions.  Anecdotal evidence 
suggests that CNS tuberculosis may be more common when initial 
antituberculous therapy has failed, when there is a relapse of disease 
or when multidrug resistant organisms cause disease.  Diagnosis of 
CNS tuberculosis is still difficult because of the lack of rapid 
diagnostic tests.  Polymerase chain reaction based techniques are used 
for their purpose.  Criteria used for diagnosis of TBM were those 
previously established by Ogawa et al.  A definite diagnosis of TBM 
was made by isolation of M. tuberculosis from the CSF or the 
presence of TBM was established by pleocytosis of the CSF and 
negative bacterial and fungal cultures (including the determination of 
bacterial antigens and cryptococcal antigen) and at least one of the 
following 1) a positive tuberculin skin test; 2) evidence of tuberculosis 
outside the CNS or previous active tuberculosis; 3) CSF glucose levels 
less than 40mg/dl; and (4) CSF protein levels greater than 0.60g/l. 
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Nontuberculous mycobacterial CNS infections due to 
Mycobacterium avium complex and Mycobacterium kansasii have 
also been described. 
 
Bacterial infections 
Pyogenic bacterial infections have been increasingly noted over 
the course of the HIV epidemic and these infections may precede the 
onset of severe immuodeficiency.  Neurological infection with 
pyogenic bacteria such us pneumococci and nonpyogenic bacteria like 
Listeria have been reported though it occurs as a very rare event in 
HIV patients. 
 
NEOPLASMS 
Primary CNS Lymphoma 
The first reports of PCNSL in HIV infected patients were 
published with the initial description of AIDS in 1982.  Recently, 
there has been a dramatic increase in the incidence of PCNSL in 
association with AIDS.  It is estimated that 1% to 2% of all HIV 
infected patients will develop PCNSL.  Epstein Barr virus has been 
implicated as causative for both systemic and primary CNS lymphoma 
in association with AIDS or other immunocompromised States.  The 
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prevalence of EBV in AIDS-associated PCNSL has been reported to 
range between 94% and 100%. 
 
Unlike systemic NHL which can occur at any stage of HIV 
infection, PCNSL typically occurs in profoundly 
immunocompromised patients with CD4+ T - Iymphocyte counts 
below 50cells/mm.  Alteration in the level of consciousness and focal 
neurological deficits are the most common presenting signs of 
PCNSL.  Seizures occur in 23% of AIDS patients with PCNSL while 
cranial nerve deficits are evident in 13% Signs of increased 
intracranial pressure are less common.  The major difference in 
presentation between AIDS and non-AIDS related PCNSL are the 
high prevalence of B symptoms and the shorter duration of symptoms 
(days to weeks versus months) for patients with HIV related tumors. 
 
Although no radiological finding is pathognomic for PCNSL, 
some radiological features are suggestive of the diagnosis.  A 
homogenously enhancing lesions in the central gray matter or corpus 
callosum is highly suggestive of PCNSL.  Ring like lesions may occur 
in 5% to 10% of cases.  Most lesions are adjacent to an ependymal or 
meningeal surface with varying degrees of edema and mass effect.  
About 50% to 60% of lesions are located peripherally in the 
 32
hemispheric gray matter or adjacent white matter.  Another 25% of the 
lesions will be found in the deep midline structures of the septum 
pallucidum, basal ganglia or corpus callosum. 
 
Kaposi's Sarcoma 
CNS involvement by Kaposi's sarcoma is distinctly unusual.  
Common signs and symptoms include cranial nerve palsies and 
polyradiculopathy and less commonly myelopathy due to epidural 
metastasis with spinal cord compression.  Intraparenchymal mass 
lesions are uncommon. 
 
MISCELLANEOUS 
Cerebrovascular complications 
HIV infected patients are at increased risk for cerebral 
infarction.  A large study of patients with AIDS (n = 1,286) found 
1.6% to have cerebrovascular complications.  There is a broad 
spectrum of etiologies, but in many cases the pathogenesis of this is 
unclear.  Cerebral granulomatous angitis due to inflammation in the 
walls of large and medium sized vessels can result in thrombosis and 
infarction.  Both intracerebral and leptomeningeal arteries may be 
involved.  Varicella zoster infection as well as syphilis may produce 
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cerebral infarction.  Nonbacterial thrombotic endocarditis also may be 
responsible in a number of cases. 
 
CT and MRI may show the sequelae of cerebrovascular disease, 
including parenchymal haemorrhage, infarction, subarachnoid 
harmorrhage, and communicating hydrocephalus.  Hypodensity is 
seen on CT, involving both gray and white matter, conforming to a 
vascular distribution.  MRI often demonstrated infarction before 
detection by CT, with increased signal seen on proton density and 
T2WIs.  Enhancement of arterial structures on MRI may indicate 
sluggish flow and may be an early sign of infarction. 
 
Seizures 
 Seizure may be consequence of opportunistic infections, 
neoplasms or HIV encephalopathy. The seizure threshold lower in 
these patients owing to frequent electrolyte abnormalities. 
 Seizure seen in, 
 Cerebral Toxoplasmosis : 15% to 40% 
 Primary CNS Lymphoma : 15% to 35% 
 Cryptococcal Meningitis : 8% 
 HIV Encephalopathy : 7% to 50% 
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 Seizures also seen in patients with CNS tuberculosis, aseptic 
meningitis, and progressive multi focal leuco encephalopathy. 
 
 In D.M. Holtzman (1997) study, 100 patients with HIV 
infection presenting with a first seizure, cerebral mass lesion was most 
common cause, responsible for 32 of the 100 new onset seizure. Of 
these 32 cases, 28 were due to toxoplasmosis , four lymphoma, HIV 
encephalopathy associated for an additional 24 new onset seizures.  
Cryptococcal meningitis was the third most common diagnosis 
responsible for 13 of the 100 seizures. In 23 cases no cause could be 
found and these cases represents subcategory of HIV encephalopathy. 
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MATERIALS AND METHODS 
 
PLACE OF THE STUDY 
This study was conducted at the Government Mohan 
Kumaramangalam Medical College Hospital, Salem.  Patients 
admitted to the wards of the internal medicine and Infectious Disease 
wards were subjects of the study. 
 
PERIOD OF STUDY 
January 2006 to July 2007. 
 
DESIGN 
Prospective Randomised cross sectional study. 
 
METHODOLOGY 
HIV patients admitted at G.M.K.M.C. Hospital were chosen for 
the study.  Random selection of patients were made in whom a 
detailed history and clinical evaluation which included the mini 
mental score (MMSE) was done, after an informed consent from the 
patient or relative. 
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The following investigation were done to all patients studied 
(i.e), when tested positive for HIV. 
 
1. Complete blood count. 
2. Renal function test (Sugar, Urea, Creatinine and 
Electrolytes) 
3. Liver Function Test (Bilirubin, AST, ALT, SAP, 
Albumin) 
4. Chest X-ray - P.A View 
5. VCTC 
6. CD4 count 
7. VDRL 
 
All patients with neurological systems were individualised and 
were subjected to the investigation listed based on clinical findings. 
 
1. C.S.F. 
2. CT Brain 
3. MRI Brain 
4. Creatinine Phosphokinase 
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METHODOLOGY OF INVESTIGATION 
HTV testing and CD4 count were done by microbiology 
department in our hospital as per NACO Guidelines.   
CD4 count was done with Facs Count (Automated Counter). 
Tests were done in a single laboratory by the same person, no 
intrapersonal error was possible.   
 
EXCLUSION CRITERIA 
Immuno Compromised state due to any other cause.   
 
LIMITATIONS 
• Culture and PCR for mycobacterium could not be done. 
• Viral Serology was done only in selected patients. 
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RESULTS AND OBSERVATIONS 
 
INCIDENCE 
31 Patients had neurological manifestations among the 100 
Patients studied.  The incidence of neurological manifestations in HIV 
infection, in this study is 31% 
 
SEX DISTRIBUTION 
Of the 100 Patients studied 80 were male and 20 were Female.  
Among the 80 males, 28 had neurological manifestations and of the 20 
Females, 3 had neurological Symptoms. 
 
TABLE NO. 1 - shows the sex distribution in this study 
Sex Positive Negative Total 
28 52 80 
Male 
35% 65% 80% 
3 17 20 
Female 
15% 85% 20% 
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AGE DISTRIBUTION 
TABLE NO.2 – shows the age distribution in this study 
Age in Years Positive Negative Total 
<30 4 25% 
15 
75% 19 
31-40 19 31.6% 
41 
68.3% 60 
>40 38 40% 
13 
62% 21 
 
Majority of the patients in our study were between 31-40 yrs of 
age.  Of the 60 Patients, who were in the age group of 31-40, 19 
(31.6%) had neurological symptoms. 
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OCCUPATION 
 
TABLE NO. 3: shows the various occupations involved in this 
study 
Occupation Positive Negative Total 
Agriculture 3 33.33% 
6 
66.66% 9 
Daily Labourer 5 23.80% 
16 
76.19% 21 
Driver 14 56% 
11 
44% 25 
House Wife 3 17.64% 
14 
82.35% 17 
Skilled Worker 2 50.008% 
2 
 50.00% 4 
Unskilled Worker 4  28.57% 
10 
 71.42% 14 
Unemployed 0  4 100% 4 
Social Worker 0 1 100% 1 
Business 0 4  100% 4 
Government Employee 0 1 100 1 
 
In our study most of the patients were drivers (56%) and 
neurological symptoms were also Common among these group of 
patients. 
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MODE OF TRANSMISSION 
All Patients in this study group had Hetero Sexual behaviour as 
the mode of transmission.   
TABLE NO. 4 
Mode of Transmission Frequency Percentage 
Hetro Sexual 100 100% 
Homo Sexual - - 
 
PRE – EXISTING INFECTION 
Among 31 Patients who had neurological symptoms, 4 Patient 
had pulmonary TB as co infection. 
 
TABLE NO.5 
Co Infection Frequency Percentage 
Pulmonary TB 
(Sputum Negative) 4 12.9% 
Nil 27 87.1% 
 
 44
 
 
CHART – 3  
PRE – EXISTING INFECTION 
 
4
27
Pulmonary TB 
Nil
 45
PHYSICAL ACTIVITY STATUS IN PATIENTS WITH 
NEUROLOGICAL SYMPTOM 
TABLE NO. 6 
 Frequency Percentage 
Ambulatory 19 63.33% 
Working 9 29.03% 
Bed Ridden 3 9.67% 
 
19 Patients in the study group who had neurological 
manifestation were Ambulatory (i.e. able to do their daily activities 
but not working), 9 were working and 3 were bed ridden. 
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CLINICAL PRESENTATIONS 
This table shows the various Clinical Presentations and their 
frequency in the Patients having neurological Manifestations. 
 
TABLE NO. 7 
Clinical Presentation Frequency Percentage 
Headache 22 38.6% 
Altered Sensorium 14 24.6% 
Hemiplegia 3 5.3% 
Seizures 8 14.0% 
Paraperesis 4 7.0% 
Quradriperesis 2 3.5% 
Parasesthesias 2 3.5% 
Cerebellar Syndrome 2 3.5% 
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DISEASE PATTERN 
 
Shows the disease patterns among patients who had 
neurological manifestations. 
 
TABLE NO. 8 
Diagnosis Frequency Percentage
Acute Flaccid Paralysis 1 3.22% 
AIDS Dementia Complex 1 3.22% 
Cerebellar Syndrome 1 3.22% 
Cryptococcal Meningitis 1 3.22% 
Toxoplasmosis 1 3.22% 
Cerebrovascular Accident 3 9.67% 
Guillian Barre Syndrome 1 3.22% 
HIV Myelopathv 1 3.22% 
Meningoenceephalitis (Cause not 
determined) 1 3.22% 
Multiple Granuloma 1 3.22% 
Myopathy 1 3.22% 
Peripheral Neuropathy 2 6.44% 
Pyogenic Meningitis 2 6.44% 
Seizure Disorder 2 6.44% 
TB Meningitis 11 35.4% 
Tuberculoma 1 3.22% 
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OUT COME 
TABLE NO. 9 : shows the outcome in the study 
Out Come Frequency Percentage 
Improved 20 64.52% 
Expired 11 35.48% 
 
11 Patients who had neurological manifestations in the study 
group expired (35.48%) and 20 Patients had improvement in their 
clinical condition. 
 
CD4 COUNT CORRELATION 
TABLE NO.10 
CD4 Count  
Mean SD 
Patient with Neurological Manifestation 179.19 113.16 
Patient without neurological Manifestation 225.03 134.58 
 
CD4 count levels in Patients with neurological manifestations 
ranged from 11 and 535 with an average of 179.19.  The average CD4 
levels in Patients without neurological manifestations was 225.03.  
There was no statistically significant difference between the two 
groups.  (P>0.05) 
 
 54
CD4 CORRELATION WITH MORTALITY 
TABLE NO.11 
Out Come CD4 Mean Count SD 
Expired 108.38 41.65 
Improved 268.60 110.94 
 
The mean CD4 Count of the patients who expired was 108.38.  
Mean CD4 count of the patients and who improved were 231.78 and 
268.60.  There is a statistically significant correlation of CD4 count 
among patients who expired (P-0.003**). 
 
CD4 CORRELATION WITH TB MENINGITIS 
There were 10 Patients diagnosed to have TB Meningitis.  CD4 
Count for one Patient was not done as the patient died before blood 
was taken for CD4 count.  The mean CD4 count of patients with TB 
Meningitis in the study group was 120.88 and the mean CD4 count of 
patients who did not have any neurological manifestations was 225.02.  
Statistically significant different of CD4 count was observed between 
the two groups.  (P-0.025*). 
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TABLE NO.12 
 No. of Cases Mean SD 
Patients with TB Meningitis 11 140.88 43.161 
Patients without 
Neurological Manifestation 69 245.02 138.585 
 
MINI MENTAL SCORE 
TABLE NO.13 
MMSE 
 
Mean SD 
Patient with Neurological Manifestation 24.94 2.13 
Patient without neurological Symptoms 26.65 .84 
 
Mini mental Score of Patients with neurological symptoms was 
compared with those without neurological symptoms.  Significant 
difference was observed in patients with neurological symptoms, P 
value being less than 0.001. 
 
FUNDUS 
Fundus Examination was done for all co-operative patients. 10 
patients had features of papilloedema and no patient had features of 
HIV Retinitis. 
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CSF ANALYSIS 
Analysis was done for 20 patients in the study. 
11 Patients had elevated proteins and predominant lymphocytes. 
4 Patients had normal CSF.   
2 had elevated proteins and acellular smear.   
2 patients had predominant neutrophils. 
1 had elevated proteins and occasional lymphocytes and also 
had positivity for cryptococcus in India Ink preparation. 
 
CT BRAIN 
24 Patients in the study were subjected to CT Brain among 
which 3 patients had middle cerebral arterial territory infarct and 1 had 
multiple calcified granulomata. 
 
MRI 
In this study 4 patients had MRI brain done for them.  1 had 
multiple ring enhancing lesions who was diagnosed to have 
Tuberculoma and other patients had features suggestive of normal 
pressure hydrocephalus. 
DISCUSSION 
 
In this study, of the 100 seropositive patients, 31 had 
neurological manifestations (31%).  The incidence of neurological 
manifestations in HIV positive patients according to snider et al was 
31% and levy et al was 39%.  In India Gupta et al found an incidence 
of 25.75% in his study. 
 
AGE 
Most of the patients in this study were in the age group of 31 - 
40 (59.38%).  The mean age of the patients with neurological 
manifestations in a study in university of California and Sanfransisco 
data was 37.3 years.  Mean age in this study was 35.63 years. 
 
SEX 
Male patients were found to have neurological manifestations 
more common (90.63%) as against females (9.38%).  Male to female 
ratio was approximately 9:1.  Metha et al, 1999 has reported male 
predominance with male to female ratio of 12:1. 
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OCCUPATION 
High incidence of neurological manifestations was noted among 
drivers (56%), followed by daily wages with 23%.  Perhaps these 
patients more often seek medical help in government hospital and also 
because HIV infection rate are high in this group of patients. 
 
MODE OF TRANSMISSION 
All patients with neurological manifestations had heterosexual 
behaviour as the risk factor.  None of our patients had homosexual 
relationship.  Gupta et al found heterosexual relationship in 64.7%, 
5.85% in drug abusers and blood transfusion in 14.7%. 
 
PRE-EXISTING INFECTION 
Pulmonary Tuberculous was present in four patients with 
tuberculous meningitis.  
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CLINICAL PRESENTATION 
 
HEADACHE 
This was the commonest presenting symptom in this study. 22 
of the 31 patients with neurological symptoms, presented with 
headache (38.6%).  16 patients (72.72%) had opportunistic infections 
like tuberculous meningitis, cryptococcosis and pyogenic meningitis 
as the cause.  Six other patients had HIV dementia and multiple 
granulomata as the cause. 
 
Headache is an extremely common symptom in HIV infection, 
because of the frequency of intracranial infection and mass lesions.  
Saag, Gray Bill et al has described headache as a common symptom in 
HIV infection frequently. 
 
ALTERED SENSORIUM 
14 out of the 31 patients, had altered sensorium (24.6%).  
Altered sensorium as observed in this study was primarily due to a 
meningeal infection, tuberculous meningitis being most frequent, 
followed by cryptococcal and pyogenic meningitis.  None of the 
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patients in this study had CNS lymphoma.  University of California 
and Sanfransisco data revealed altered sensorium as a manifestation in 
secondary viral infection.  Progressive multifocal 
leucoencephalopathy, toxoplasmosis, cryptococcosis, HIV dementia 
and lymphoma. 
 
SEIZURES 
In our study, the common cause for seizures was 
neurotuberculosis.  Of the 31 patients, 8 patients had seizures (14%).  
Two patients had normal CT brain and C.S.F analysis did not reveal 
any abnormality.  EEG could not be tested to the above patients. 
 
This is perhaps because approximately half the HIV infected 
patients have no definite identifiable disease of the brain and cerebral 
HIV infection seems to be the likely cause of the seizures, as reported 
by Holtzman et al AMJ Med. 1989 study which had HIV 
encephalopathy as the cause of seizures in 24% of the patients. 
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PARAPARESIS 
4 patients had paraparesis on presentation in our study (7%).  Of 
the 4, one was due Guillian - Barre syndrome and 3 due to HIV 
myelopathy. 
 
Human T cell lymphotrophic virus 1, tuberculosis, herpes zoster 
and syphilis were the causes of paraparesis described by A.I Bhigjee et 
al in their study. 
 
PARAESTHESIAS 
Two patients in our study had paraesthesias of both lower limb 
(3.5%).  One patient was on antiretroviral therapy (which included 
zidovudine) and other patient was not on ART. Both were improved 
with amitryptilline and nutritional support. 
 
Fuller, Le Fauchur et al (2001) has shown an incidence of 
9.46% of peripheral neuropathy in his study. 
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CEREBELLAR SYNDROME 
Of the 31 patients 1 had features of cerebellar syndrome 
(3.22%).  One patient had an hypodense lesion in the cerebellar area in 
the CT brain (plain). 
 
Mc Arthur et al (1998) had noticed gait disturbance and 
clumsiness in 45% of patients with HIV dementia. 
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Comparative Table : 1 
 Vijay D. Teja et al This study 
Number of Patients 100 100 
Incidence 32 % 31% 
Headache 13 (40.63%) 22 (38.6%) 
Altered sensorium 14 (20.6%) 14(21.6%) 
Hemiplegia 4 (12.5%) 3(5.3%) 
Seizures 8(25.07%) 8 (14.0%) 
Paraparesis 6 (18.75%) 4(7.0%) 
Paraesthesias 3 (9.35%) 2(3.5%) 
Cerebellar Syndrome 3 (9.35%) 2 (3.5%) 
Involuntary 
Movements
1 (3.13%) -- 
Psychosis 3 (9.35%) -- 
 
AIDS DEMENTIA COMPLEX 
Among the 31 patients, one had AIDS dementia complex 
(3.22%).  Patient presented with headache and progressive cognitive 
decline.  Mini mental score of the patient was 20. CT brain and C.S.F 
analysis were normal. 
 
Impaired memory and concentration with psychomotor slowing 
represent the common early presentation of this disorder. 
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Vijay D. Teja et al (2005) reported 8.03% incidence in their 
studies.  In view of these findings baseline MMSE is probably 
advisable for all cases with HIV seropositivity and periodic evaluation 
may unearth more cases with AIDS dementia complex. 
 
PERIPHERAL NEUROPATHY 
In our study two patients had peripheral neuropathy (6.44%).  
Both the patients presented with paraesthesias and were foot drop. 
One was taking antiretroviral therapy which included zidovudine and 
other not on antiretroviral. 
  
HIV associated sensory neuropathies include both distal sensory 
polyneuropathy due to HIV infection and antiretroviral toxicity.  It is 
very difficult to differentiate between the two.  Treatment is largely 
symptomatic.  Our patients improved with change of retro viral 
regimen, amitryptilline and nutritional support. 
 
MYOPATHY 
One patient in our study had myopathy (3.22%).  The patient 
presented with myalgia, proximal muscle weakness.  On investigating 
further he had elevated creatinine kinase levels.  Patient was on 
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antiretroviral therapy.  After stopping zidovudine patient was followed 
up, with improvement in symptoms. 
 
Studies have suggested that zidovudine induced myopathy 
occurs only when an underlying HIV related inflammatory myopathy 
is present. 
 
HIV MYELOPATHY 
Of the 31 patients in the study, two had HIV related myelopathy 
(6.44%).  Patient had lower limb weakness and urinary incontinence 
on presentation.  MRI spine showed no abnormalities and C.S.F 
analysis was normal.   
 
Jerez.p et al (2001) have shown 22% incidence of spinal lesions 
in AIDS.  Leading cause of myelopathies described in association with 
HIV was vacuolar myelopathy followed by myelitis. 
 
NEUROTUBERCULOSIS 
12 out of 31 patients who had neurological symptoms in our 
study had tuberculous infection of the nervous system.  Among the 12 
patients, 11 had tuberculous meningitis (35.4%) and 1 had 
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tuberculoma (3.22%).  3 of the 11  patients with tuberculous 
meningitis expired (27.27%). 
 
The patient diagnosed with tuberculoma presented with 
headache and partial seizures involving left upper limb.  MRI brain 
revealed multiple ring enhancing lesions.  C.S.F analysis showed 
elevated protein with predominant lymphocytes. 
 
Increased number of neurotuberculosis in Indian studies is 
probably due to the high prevalence of tuberculosis in this part of the 
world. 
 
In all our patients tuberculous meningitis was the first 
manifestation of the disease.  Among them five patients on 
Antiretroviral therapy.  
 
PYOGENIC MENINGITIS 
2 patients had features of pyogenic meningitis (6.44%).  Both 
the patients presennted with altered sensorium, fever and headache.  
CT brain was normal and C.S.F analysis revealed elevated proteins 
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and predominant neutrophils in cytology.  C.S.F culture did not grow 
any organism. 
 
Both the patients however succumbed to the disease proving the 
point that pyogenic infection coexisting with HIV infection has very 
high mortality. 
 
AIDS related CNS complication from bacterial pathogens have 
not been reported from western studies. 
 
Studies from NIMHANS – S.K. SANKAR, ANITHA 
MAHADEVAN et al (2005) show 9% incidence of Bacterial 
meningitis.  
 
CRYPTOCOCCAL MENINGITIS 
Of the 31 patients one had cryptococcal meningitis (3.22%).  
Headache, altered sensorium and signs of meningeal irritation was the 
presentation.  C.S.F analysis in this patient was positive for 
Cryptococcus on India ink preparation. 
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Bandypadhyay et al in his study had 3.7% incidence of 
cryptococcal meningitis. 
 
TOXOPLASMOSIS 
Of 31 patients one had toxoplasmosis (3.22%). Head ache and 
fever was the presentation. IgG Ab  positive for Toxoplasmosis and 
MRI was normal. 
 
SINGH et al in his studies shows 3.6% incidence of 
Toxoplasmosis. 
 
CEREBROVASCULAR ACCIDENT 
3 patients in our study presented with cerebrovascular 
complications (9.66%).  All three patients presented with hemiparesis 
and their CT brain showed middle cerebral arterial territory infarct.  
On admission and he expired on the same day.  Evaluation of the 3 
patients for young stroke showed no abnormalities. 
 
Gupta et al has reported 8.82% incidence of CVA in 
seropositive patients in his study. 
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There is a broad spectrum of etiologies causing this scenario but 
in many cases the pathogenesis is unclear.  Cerebral granulomatous 
angitis due to HIV infection could result in vascular occlusive disease. 
 
GUILLIAN-BARRE SYNDROME 
Among the 31 patients with nerological symptoms, 1 had 
Guillian – Barre syndrome (3.22%). Both the patients presented with 
features of ascending paralysis.  C.S.F analysis showed elevated 
protein with acellular smear cytology.  Nerve conduction study and 
Oligoclonal band in C.S.F could not be done. 
 
HIV–GBS occurs in early and late stages of HIV infection, and 
may follow onset of AIDS.  TH Brannagan et al had reviewed 10 
patients with HIV–GBS between 1986 and 1999, in which GBS was 
first symptom of the HIV infection in 3 patients. 
 
SEIZURE DISORDERS 
Two patients in this study group presented as seizure disorder 
(6.44%).  One patient presented with generalized seizure. CT brain 
and C.S.F analysis were normal in both the patients.  EEG could not 
be done. 
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Approximately half of HIV infected patients with seizures have 
no definite identifiable disease of the brain and cerebral HIV infection 
seems to be the most likely cause of the seizures. It the study by 
Holtzman et al, HIV encephalopathy was responsible for seizures in 
24% of the patients. 
 
MULTIPLE GRANULOMATA 
In our study one patient presented with chronic headache of 6 
months duration.  CT brain done on the patient showed multiple 
calcified granulomas.  C.S.F analysis revealed no abnormality.  As the 
patient could not afford MRI brain was not done.  Patient was 
empirically treated with albendazole with no apparent improvement on 
immediate follow up. 
 
MORTALITY 
20 out of the 31 patients who had improved outcome (35.48%). 
 
As improved Antiretroviral Therapy, nutritional and social 
support continues to the prolong life span of HIV infected persons. 
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Comparative Table: 2 
 Gupta et al Vijay D. Teja  et al Our study 
Year of Study 1993 2005 2007 
Incidence 25.75% 32% 31% 
Mode of 
transmission 
Heterosexual - 
64.5% 
I.V Drug abuser - 
5.85 % 
Blood transfusion -
14.7 % 
Heterosexual   
–100% 
Heterosexual 
- 100% 
AIDS dementia 
complex 17.65% 3.13% 3.22% 
Peripheral 
neuropathy 8.82% 6.25% 3.5% 
Neurotuberculosis 58.82% 31.25% 35.4% 
Cryptococcal 
meningitis 8.8% 3.13% 3.22% 
Neurosyphilis -- 3.13% -- 
PML -- 3.13% -- 
Myopathy -- 3.13% 3.22% 
Toxoplasmosis 3.8% -- 3.22% 
CVA 8.82% 9.38% 9.67% 
Seizure disorder -- 6.25% 6.44% 
Outcome -- Poor Good 
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CONCLUSION 
 
1. Incidence of neurological illness in HIV infection in our study 
was 31%. 
 
2. All patients in our study had heterosexual transmission of 
disease. 
 
3. CNS manifestations in men were more common than in women. 
 
4. Headache and altered mentation were the two common 
symptoms observed in this study. 
 
5. Tuberculous meningitis was the most commonest opportunistic 
infection in our study. 
 
6. No significant CD4 count correlation was found between the 
patients with neurological manifestations and those without 
neurological manifestations. 
 
7. CD4 count when less was associated with increased mortality. 
 
8. Patients with coexisting tuberculous meningitis and HIV 
infection had significantly lower CD4 counts. 
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9. Tuberculous meningitis was associated with good outcome and 
pyogenic meningitis had high mortality. 
 
10. Patients with neurological manifestations had good outcome 
and low mortality.  
 
 
 74
SUMMARY 
 
We study 100 consecutive HIV sero positive patients from 
January 2006 to July 2007 of them 31 had neurological 
manifestations.   Out of which TB meningitis constituted major part.   
 
The following were the details of neurological manifestations.  
Tuberculous meningitis(35.4%), cerebrovascular complications 
(9.67%), Guillian barre syndrome (3.22%), pyogenic meningitis 
(6.44%), peripheral neuropathy (6.44%), seizure disorders (6.44%), 
acute flaccid paralysis (3.22%), AIDS dementia complex (3.22%), 
cerebellar syndrome (3.22%), cryptococcal meningitis (3.22%), 
Toxoplasmosis (3.22%), HIV myelopathy (3.22%), 
meningoencephalitis - cause not determined (3.22%), multiple 
granulomata (3.22%), myopathy (3.22%), Tuberculoma (3.22%). 
 
Mortality increased most with coexisting meningitis and with 
decreased CD4 counts. 
 
Commonest neurological condition associated was 
neurotuberculosis. 
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PROFORMA 
 
Name :  Age :    Sex : 
Place :  Occupation :  Date of Admission: 
Hospital No. :     Date of Discharge : 
 
PRESENTING COMPLAINTS : 
Past History :  Yes  No 
Diabetes Mellitus 
Hypertension 
H/O Tuberculosis 
H/O Exposure to a case of tuberculosis 
 
PERSONAL HISTORY 
Marital Status : 
Diet :   Appetite :   Sleep : 
Bowel :  Bladder  : 
Habit :  Alcohol  :   Yes  No 
   Smoking :    Yes  No 
   Tobacco Chewing : Yes  No 
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RISK FACTORS YES NO 
Heterosexual   
Homosexual   
I.V. Drug Abuser   
 
GENERAL PHYSICAL EXAMINATION : 
Built & Nourishment : 
Pallor :   Icterus :   Cyanosis: 
Clubbing : 
Pedal edema :  Lymph nodes: 
Oral Cadidiasis : 
Herpes Zoster : 
Glossitis  
VITAL SIGNS: 
Pulse : 
Blood Pressure : 
Temperature : 
Respiratory Rate : 
Weight : 
NERVOUS SYSTEM EXAMINATION: 
Higher Mental Functions : 
 90
Mini Mental state examination score: 
Cranial Nerves : 
Fundus: 
Motor System Examination :  Upper Limb 
      Lower Limb 
Reflexes : Superficial Reflexes 
  Deep Tendon Reflexes  
Co-ordination : 
Involuntary Movements : 
Sensory System Examination : 
Primitive Reflexes : 
Signs of Meningeal Irritation : 
Gait : 
Skull & Spine : 
Peripheral Nerves : 
Other Systems : CVS 
   RS 
   PA 
INVESTIGATIONS: 
Hb 
TC 
 91
DC 
ESR 
Urine Routine 
LFT 
RFT 
Serum Electrolytes 
Blood Sugar 
Chest X-Ray 
Sputum Examination 
CEREBROSPINAL FLUID STUDY: 
Cell – Count 
 Type 
Proteins 
Sugar 
Staining 
Culture 
Others 
SPECIAL INVESTIGATIONS: 
FINAL DIAGNOSIS: 
COURSE IN THE HOSPITAL: 
 
S. 
No. Name Age Sex Occ Mot
Clinical 
Presentation CT MMSE CSF CT MRI Diagnosis Outcome
1 Moorthy 28 M DL HS 120 27
2 Gunabalan 40 M Agri. HS Headache, Stiffneck 114 26 ↑ L, Pr. Normal - TBM Good
3 Mohan 39 M Driver HS 186 26
4 Thangavelu 47 M DL HS 206 26
5 Sekar 49 M Driver HS 536 27
6 Santha 36 F HW HS Convulsion, AS 168 28 Normal Normal SD Good
7 Karuppannan 36 M DL HS Lt. Foot drop 180 28 PN Good
8 Arthanari 35 M Driver HS 226 28
9 Sangeetha 24 F HW HS 214 25
10 Munusamy 40 M Agri. HS AS, Headache 80 - ↑ Pr, No. Normal PM Expired
11 Chelladurai 40 M DL HS 288 27
12 Perumal 42 M DL HS 94 -
13 Revathi 32 F HW HS 529 24
14 Kumari 36 F HW HS 50 -
15 Selvarani 40 F HW HS 178 -
MASTER CHART
16 Natarajan 45 M Driver HS Headache, AS 254 25 Normal TBM Good
17 Vanitha 23 F HW HS 286 24
18 Vijaya 28 F HW HS 222 26
19 Madhu 46 M Driver HS 136 26
20 Sivakumar 46 M DL HS 177 28
21 Solomon 38 M DL HS 168 24
22 Dharman 41 M DL HS 190 27
23 Murugesan 30 M Driver HS 366 27
24 Vairavel 40 M DL HS 30 27
25 Santhakumar 30 M DL HS 50 27
26 Kaviarasu 31 M Driver HS Headache,  AS 80 24 ↑ L, Pr. Normal TBM Good
27 Santhanam 30 M Driver HS Weakness of Limbs (UL & LL) 136 27 ↑ Pr. Normal AFP Expired
28 Kaliyamurthy 36 M DL HS 164 26
29 Rajamani 30 M DL HS 225 26
30 Ansari 35 M SW HS 236 28
31 Jeyaraj 29 M DL HS Foot Drop 330 28 Normal PN Good
32 Rajan Babu 31 M Driver HS 364 27
33 Kumaravelu 29 M DL HS 408 26
34 Palanisamy 42 M Agri. HS 480 26
35 Subrathinam 33 M DL HS 540 26
36 Selvakumar 32 M Driver HS AS, Headache 89 - ↑  Pr. Normal PM Expired
37 Raja 40 M DL HS Headache, Convulsion 124 27 ↑ L, Pr. Normal TBM Good
38 Anbarasu 39 M DL HS 176 23
39 Indrabalan 43 M DL HS 212 26
40 Deepak Lal 41 M DL HS 264 27
41 Chenniappan 39 M UE HS AS & SN 344 - ↑ No. Normal Normal ME Expired
42 Velraj 29 M Driver HS 365 27
43 Kasiraj 33 M UE HS 412 27
44 Semaraj 31 M Business HS V, Headache, SN 65 - ↑ Pr. G 
Normal
Normal Toxo Expired
45 Irusappan 29 M Agri. HS Convulsion 142 - ↑ L, Pr. Normal TBM Good
46 Jeyakumar 42 M Business HS 171 28
47 Prabu 47 M DL HS 213 22
48 Riyaz 31 M Driver HS Weakness of Limbs (UL & LL) 289 27
Infarct 
MCA (T) CVA Rt. HP Expired
49 Kalaiselvi 32 F HW HS 325 28
50 Sivakumar 33 M Govt.E. HS Weakness of Limbs (UL & LL) 376 28 Normal Normal Normal HIV, Myelopathy Good
51 Kamal Hussain 29 M UE HS 513 22
52 Anand 36 M SW HS AS & Headache 94 Indianink +ve Normal Crypto Expired
53 Ebinezer 39 M Driver HS 125 27
54 Selvan 41 M DL HS 177 28
55 Madhan 47 M UE HS 220 24
56 Saravanan 33 M UE HS Convulsion 253 26 Multiple Gr lesion
Multiple 
Granuloma Good
57 Palanivel 53 M Driver HS 324 27
58 Muthu 40 M UE HS AS 91 ↑ L, Pr. Normal TBM Expired
59 Arumugam 60 M UE HS 114 23
60 Nagarajan 37 M NE HS 200 28
61 Seetha 29 F HW HS Headache, Fever 206 27 ↑ L, Pr. Normal TBM Good
62 Muniyan 32 M Agri. HS Weakness of Limbs (UL & LL) 291 27
Rt. MCA 
infarct CVA. Lt. HP Expired
63 Maharaja 34 M Driver HS 54 28
64 Jone 36 M Business HS Headache, Fever 136 26 ↑ L, Pr. TBM Good
65 Rajaya 43 M Driver HS Weakness of Limbs (UL & LL) 128 27 ↑ Pr. Normal GBS Expired
66 Ganesan 37 M Agri. HS Weakness of Limbs (UL & LL) 98 24
Lt. MCA 
infarct CVA Rt. HP Good
67 Devendran 39 M Driver HS 77 22
68 Chellaiyan 40 M Driver HS Unsteadiness 102 26 Hypodense Lt. Normal
Cerebellar 
Syndrome Good
69 Palanisamy 31 M Agri. HS 54 27
70 Chinnupaiyan 35 M Agri. HS 194 28
71 Singaravelu 50 M Business HS 206 26
72 Selvi 26 F HW HS 176 27
73 Chinnayyan 36 M Driver HS Headache, V, Fever 209 27 ↑ L, Pr. Normal TBM Good
74 Periyasamy 40 M Driver HS 189 27
75 Kalakumari 34 F HW HS 236 26
76 Vijaya 20 F HW HS 111 24
77 Veeramuthu 33 M Agri. HS 178 26
78 Raji 21 F DL HS 210 27
79 Madanlal 37 M DL HS 285 28
80 Kumari 24 F HW HS 134 28
81 Rathinaselvi 29 F HW HS 176 -
82 Hamitha Begam 42 F HW HS 286 28
83 Valli 33 F HW HS Convulsion 324 28 Normal Normal Seizure Decoder Good
84 Jeyapal 23 M Driver HS Headache & AS 101 22 ↑ L, Pr. Normal TBM Good
85 Rajaselvan 56 M Driver HS AS 161 - Normal Normal ADC Expired
86 Sankar 39 M So.W HS 215 27
87 Anbuselvi 33 F HW HS 257 27
88 Muthu 35 M UE HS Headache, Convulsion 116 22 Normal
Ringleisi
on Tuberculoma Good
89 Jeyapriya 37 F HW HS 173 27
90 Jegatheesan 53 M So.W HS 210
91 Raja 49 M Un.SW HS Weakness, PX of muscle 251 26 Myopathy Good
92 Helen 59 F HW HS 283 28
93 Krishnan 33 M Driver HS 326 27
94 Ramasamy 53 M Driver HS 116 24
95 Dhanasekaran 46 M Un.SW HS 173 27
96 Murugesan 43 M UE HS 210 27
97 Joseph 40 M DL HS 253 27
98 Kalanjiyam 43 M DL HS 254 26
99 Prabakaran 50 M DL HS AS 126 23 ↑ L, Pr. Normal TBM Good
100 Sekar 39 M DL HS 191 -
MOT - Mode of Transmission PX - Proximal
Occ - Occupation L - Lymphocyte
MMSE - Minimental Score Examination Pr - Protein
CT - Computer Tomography G - Glucose
MRI - Magnetic Resonance No. - Neutrophil
DL - Daily Labour MCA - Middle Cerebral Atery
Agri. - Agriculture HP - Hemiparesis
HW - House Wife TBM - Tuberculosis Meningits
SW - Skilled Worker PN - Peripheral Neuropathy
UE - Unemployed SD - Seizure Disorder
NE - Not Employed PM - Pyogenic Menengitis
Govt. E - Govt. Employed AFP - Acute Flaccid Paralysis
So.W - Social Worker Toxo - Toxoplasmosis
Un.SW - Unskilled Worker ME - Meningo-Encephalitis
HS - Hetro Sexual Crypto - Cryptococcocis
AS - Altered Sensorium GBS - Gullian - Barre Syndrome
UL & LL - Upper Limb and Lower Limb ADC - AIDS Dementia Complex
V - Vomitting
